Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility, Interventional, Prospective Study to Enhance Features and Optimise the Clinical Pathway for the TICI Research System in Adult Cochlear Implant Recipients

NCT06642935 is registered in ClinicalTrials.gov with Cochlear as lead sponsor.

NCT NCT06642935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06642935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility, Interventional, Prospective Study to Enhance Features and Optimise the Clinical Pathway for the TICI Research System in Adult Cochlear Implant Recipients
Lead sponsor
Cochlear
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 18, 2024
Completion date
November 30, 2027
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hearing loss, bilateral or unilateral, hearing loss, cochlear, hearing loss, sensorineural